 |
October 2019
| 6th Issue
Online Registration Closes on Nov 14 |
|
In this Issue
|
|
|
|
Online Registration Closes on Nov 14 |
|
|
|
|
|
Delegates who have yet
to register please note,
online
registration for
Asia-Pacific
Vitreo-retina Society
(APVRS) 2019 will close
on Thursday, November
14, 2019 (Hong Kong
time, GMT+8).
After the deadline, all
registrations will have
to be made onsite at
NECC Shanghai.
|
 |
|
Meanwhile, advance
registration rates will
end on Sunday, November
10, 2019, at 11:59 pm
(GMT+8).
For registration of more
than 5 delegates, please
complete and return the
group registration form
to the APVRS secretariat
at
registration@apvrs.org
by November 10 as well.
Visit our Congress
website now at
http://2019.apvrs.org/registration/
for registration
details. |
|
|
|
|
APVRS Opening Ceremony &
Special Lectures |
|
|
|
|
|
The Opening
Ceremony of
the 13th
APVRS
Congress is
scheduled at
16:00 on
Friday,
November 22.
In addition
to a special
performance
and speeches
from honored
guests, the
ceremony
will feature
the
presentation
of the 2019
APVRS Tano
Lecture.
Together
with Tano
Lecture,
Constable
Lecture and
International
Award
Lecture are
the three
prestigious
named awards
of APVRS to
honor
individuals
for their
exemplary
leadership
and
significant
contributions
in advancing
the
understanding,
diagnosis,
and
treatment of
vitreo-retinal
diseases.
This year,
the awardees
are as
follows:
The
Constable
Lecture and
International
Award
Lecture will
be presented
at 16:00 on
Saturday,
November 23.
|
|
|
|
|
APVRS
2019
Tano
Travel
Grant
Recipients |
|
|
 |
|
|
|
After receiving applications from a number of highly eligible doctors, a total of 5 individuals have been selected as the 2019 APVRS Tano Travel Grant awardees. Each vitreo-retinal specialist below will receive US$500 (who lives outside China) / US$250 (who lives within China) toward their travel expenses to the 13th APVRS Congress in Shanghai. APVRS congratulates the following recipients:
|
|
|
|
|
Scientific Program Highlights |
| |
|
|
 |
|
|
|
Update on Drug Delivery to the Posterior Segment of the Eye
-
New therapeutic modalities are constantly being developed, which are vastly aiding the treatment of a variety of retinal diseases. This symposium will cover the various routes of drug administration, and will review the challenges of having the drug reach its’ intended target. New treatments in development will be extensively reviewed, along with improvements in administration of currently available medications. Time will be allotted for questions and answers.
Advances in Gene Therapy of Retinal Diseases
-
Retinal degenerative diseases are a major cause of blindness and encompass multifactorial diseases, such as Leber congenital amaurosis, Stargardt disease and retinitis pigmentosa. More than 200 known genes are associated with hereditary retinal degenerations, and there are no approved treatments for most of these disorders presented with significantly phenotypic and genetic heterogeneity. Retinal gene therapy is a trail-blazer in the human gene therapy field, leading to the first FDA approved gene therapy product for a human genetic disease. Clinicians have been at the forefront of the development of gene therapy, which brings hope for the treatment of these conditions.
High Myopia
-
This session will demonstrate the optical coherence tomographic characteristics of a classification of myopic maculopathy as well as high myopia-associated peculiarities of the choroid. Other topics relating to highly myopic eyes, including factors associated with the development of retinal changes, important points in the diagnosis and therapy of myopic choroidal neovascularization, aspects of the vitreo-retinal surgery, and the application of optical coherence tomography (OCT) and OCT-based angiography, will also be discussed.
Innovation and Controversies in Retina Surgery
-
This symposium will review new innovations and technical advances in surgical retinal diseases. The international faculty will share their perspectives on complex and difficult retinal conditions, including peeling of the internal limiting membrane, re-operations for failed macular hole surgery, proliferative vitreoretinopathy, neovascular glaucoma, pediatric retina surgery and the role of retina surgery following devastating eye trauma. The session will also highlight how emerging technology, such as OCT angiography, integrated microperimetry, indications for intraoperative OCT and 3D vitreo-retinal surgery, may improve surgical efficiency and clinical outcomes.
Swept Source OCT and OCT Angiography
-
Swept-source OCT (SS-OCT) is revolutionizing the way we diagnose and manage vitreo-retinal, retinal vascular and chorio-retinal diseases. This symposium will cover the latest real-world clinical applications of both structural and angiographic SS-OCT imaging in diabetic retinopathy, dry age-related macular degeneration (AMD), macular neovascularization due to polypoidal choroidal vasculopathy and AMD, ocular inflammatory conditions, and in normal aging. Both macular and widefield SS-OCT imaging will be discussed and compared with conventional dye-based angiography. The use of appropriate boundary-specific anatomic segmentation to obtain correct diagnoses will be emphasized.
|
|
|
|
|
Diamond, Platinum and Silver Sponsors |
| |
|
|
|
APVRS 2019 is pleased to have the following esteem organizations as the Congress sponsors:
The Congress Organizer would like to express its heartfelt appreciation and gratitude for their support! |
|
|
|
|
Touring Shanghai |
| |
|
|
|
As you are busy packing for the 13th APVRS Congress, the Congress Organizer has gathered some local tours for you to enjoy the trip to its fullest. A total of eight tours varies from half day to one day, day to night, and city center to nearby cities. You will be able to find one meeting your preference. Please note that each tour requires a minimum of 2 guests and booking should be made 2 days in advance!
*Click to enlarge each photo |
|
|
|
|
|
|
APVRS Secretariat
|
|
|
|
|
|
|
|
|
